IL6R and B-cell chronic lymphocytic leukemia: Current trials with tocilizumab, a monoclonal antibody that binds to CD126 are underway in chronic lymphocytic leukemia, breast, ovarian, and pancreatic cancer17, lend further support for our approach to target this antigen with CAR-T cells.